Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic.

BMC Immunol · 2025 · PMC12001417 · PMID 40240963

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The number of AE reports in which ICIs were identified as the primary suspected (PS) or secondary suspected (SS) agents demonstrated an increasing trend, starting from the third quarter of 2021.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.